September 19^th, 2024, at 11.30-12.30
Säätiö-Sali, Medisiina D building

Ankur Gupta, PredOmix Technologies Private Limited, India: An integrated metabolomics-based platform for early-stage detection of multiple cancers

Host: Riitta Lahesmaa ( rilahes@utu.fi )

Coffee will be served before the seminar
Organisers: MIST Research Program, BioCity Turku, Turku Bioscience Centre

***

Dr. Ankur Gupta works as the Head of Data Analytics and, with a strong background in mathematics, he leads the AI and machine learning team at PredOmix Technologies Private Limited. With a bachelor’s and master’s degree in Geophysics from the Indian Institute of Technology (IIT), Roorkee, India and a Ph.D. in Mathematics from Jadavpur University, India, Dr. Ankur has an extensive research background. He was a research fellow at the Translational Health Science and Technology Institute (THSTI), India, where he developed computational and mathematical models for host-pathogen interactions during mycobacterial pathogenesis and has published in peer-reviewed journals.

At PredOmix, Dr. Ankur leads a team of AI experts who provide end-to-end solutions for complex problems in disease diagnostics and drug discovery. His expertise in AI and machine learning is complemented by his keen interest in healthcare and drug discovery. Under his leadership, the team has developed innovative deep learning tools that integrate metabolomics and deep learning for early cancer detection.

References

1. Gupta A, Siddiqui Z, Sagar G, Rao KV, Saquib N. A non-invasive method for concurrent detection of multiple early-stage cancers in women. Scientific Reports. 2023 Nov 4;13(1):19083.
2. Gupta A, Sagar G, Siddiqui Z, Rao KV, Nayak S, Saquib N, Anand R. A non-invasive method for concurrent detection of early-stage women-specific cancers. Scientific Reports. 2022 Feb 10;12(1):2301.
3. Nagarkar R, Gopichand M, Pal SK, Gupta A, Saquib NM, Sagar G, Rao KV, Siddiqui Z, Longkumer I. The High Sensitivity of the Multi-Cancer Detection Test ONCOVERYX-F Offers a Promising Platform for Ovarian Cancer Screening. International Journal of Women’s Health. 2024 Dec 31:1-7.
4. Ramamoorthy S, Sundaramoorthy S, Gupta A, Siddiqui Z, Sagar G, Rao KV, Mohan SK, Saquib N. Beta-validation of a non-invasive method for simultaneous detection of early-stage female-specific cancers. medRxiv. 2023:2023-10.